STAGE MIGRATION AND THE INCREASING PROPORTION OF COMPLETE RESPONDERS IN PATIENTS WITH ADVANCED GERM-CELL TUMORS
- 15 June 1988
- journal article
- research article
- Vol. 48 (12) , 3524-3527
Abstract
The proportion of patients with metastatic germ cell tumors achieving complete remission increased, and the total survival improved between 1975 and 1982. Several analyses were undertaken to evaluate the influence of stage migration on treatment outcome in patients with germ cell tumors. (a) A logistic regression analysis showed that a formulation of time was an independent statistically significant variable (P = 0.025) in addition to the total number of sites of metastasis (P < 0.001) and pretreatment values of human chorionic gonadotropin (P < 0.001) and lactate dehydrogenase (P = 0.002). (b) The proportion of patients with lung metastases and elevated levels of human chorionic gonadotropin and .alpha.-fetoprotein decreased, and the number of patients with retroperitoneal metastases and without prior radiation therapy increased significantly. (c) The number of patients with a high likelihood of complete response increased significantly over time (P < 0.001). Computerized tomography of the abdomen permits detection of large but asymptomatic retroperitoneal disease, and such patients are now being treated with chemotherapy rather than surgery and are included in advanced disease treatment results. Stage migration has played a role in the increasing proportion of complete responders in clinical trials of patients with germ cell tumors.This publication has 12 references indexed in Scilit:
- Advanced Seminoma: The Role of Chemotherapy and Adjunctive SurgeryAnnals of Internal Medicine, 1988
- The Will Rogers PhenomenonNew England Journal of Medicine, 1985
- Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.Journal of Clinical Oncology, 1985
- Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group studyCancer, 1984
- Serum tumor markers in patients with metastatic germ cell tumors of the testisThe American Journal of Medicine, 1983
- VAB-5 combination chemotherapy in prognostically poor risk patients with germ cell tumorsCancer, 1983
- MULTIVARIATE-ANALYSIS OF PROGNOSTIC VARIABLES IN PATIENTS WITH METASTATIC TESTICULAR CANCER1983
- IMPACT OF DELAY IN DIAGNOSIS ON CLINICAL STAGE OF TESTICULAR CANCERThe Lancet, 1981
- VAB-3 combination chemotherapy of metastatic testicular cancerCancer, 1981
- VAB–4 combination chemotherapy in the treatment of metastatic testis tumorsCancer, 1981